AAIM
TMO icon

Asset Advisors Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Asset Advisors Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Hold
1,500
– – 0.07% 82
2026
Q1 		$737K Hold
1,500
– – 0.07% 82
2025
Q4 		$869K Hold
1,500
– – 0.08% 80
2025
Q3 		$728K Sell
1,500
-105
-7% -$48.9K 0.07% 78
2025
Q2 		$651K Sell
1,605
-9,340
-85% -$3.91M 0.06% 80
2025
Q1 		$5.45M Sell
10,945
-225
-2% -$122K 0.57% 45
2024
Q4 		$5.81M Sell
11,170
-1,386
-11% -$762K 0.61% 41
2024
Q3 		$7.77M Sell
12,556
-59
-0.5% -$34.9K 0.81% 36
2024
Q2 		$6.98M Buy
12,615
+1,430
+13% +$819K 0.76% 37
2024
Q1 		$6.5M Buy
11,185
+2,373
+27% +$1.33M 0.73% 35
2023
Q4 		$4.68M Buy
8,812
+40
+0.5% +$19.4K 0.57% 39
2023
Q3 		$4.44M Sell
8,772
-777
-8% -$414K 0.6% 39
2023
Q2 		$4.98M Buy
9,549
+75
+0.8% +$40.5K 0.63% 40
2023
Q1 		$5.46M Sell
9,474
-50
-0.5% -$28.2K 0.71% 37
2022
Q4 		$5.24M Sell
9,524
-160
-2% -$84.8K 0.69% 38
2022
Q3 		$4.91M Buy
9,684
+40
+0.4% +$22.4K 0.7% 38
2022
Q2 		$5.24M Sell
9,644
-50
-0.5% -$27.5K 0.71% 37
2022
Q1 		$5.73M Buy
9,694
+265
+3% +$152K 0.64% 37
2021
Q4 		$6.29M Buy
9,429
+755
+9% +$471K 0.63% 39
2021
Q3 		$4.96M Buy
8,674
+500
+6% +$274K 0.55% 45
2021
Q2 		$4.12M Buy
8,174
+380
+5% +$179K 0.46% 49
2021
Q1 		$3.73M Buy
7,794
+6,094
+358% +$2.91M 0.44% 48
2020
Q4 		$792K Buy
1,700
+100
+6% +$46.9K 0.1% 67
2020
Q3 		$706K Hold
1,600
– – 0.11% 64
2020
Q2 		$580K Hold
1,600
– – 0.09% 72
2020
Q1 		$454K Hold
1,600
– – 0.08% 78
2019
Q4 		$532K Hold
1,600
– – 0.08% 80
2019
Q3 		$466K Buy
1,600
+100
+7% +$28.6K 0.07% 78
2019
Q2 		$441K Hold
1,500
– – 0.07% 75
2019
Q1 		$411K Hold
1,500
– – 0.07% 80
2018
Q4 		$336K Hold
1,500
– – 0.07% 82
2018
Q3 		$366K Buy
+1,500
New +$345K 0.06% 89

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Asset Advisors Investment Management's TMO Position: Q2 2026 in Review

Asset Advisors Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,500 shares worth $752K. The position accounts for 0.07% of the portfolio, ranked #82.

Asset Advisors Investment Management first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $7.77M in Q3 2024. 925 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Asset Advisors Investment Management held 1,500 shares of Thermo Fisher Scientific worth $752K as of Q2 2026.
  • Asset Advisors Investment Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.07% of Asset Advisors Investment Management's portfolio in Q2 2026, its #82 holding.
  • Asset Advisors Investment Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
  • Asset Advisors Investment Management's Thermo Fisher Scientific position peaked at $7.77M in Q3 2024.
  • 925 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Asset Advisors Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.